LU7
Lithium Universe Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Lithium Universe Ltd. engages in the business of design and development of its online media platform. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2011-10-19. The firm has various lithium opportunities in Tier 1 mining jurisdictions in Canada and Australia. Its segments include Rare Earth exploration and Lithium exploration. Its projects include Apollo Lithium Project, Adina South & Adina West Lithium Project, Margot Lake Lithium Project, Lefroy Lithium Project, Voyager Rare Earth Project. Apollo Lithium Project is located in the same greenstone belt and only 29 kilometers south-east of the Corvette Lithium Project and covers over 240 square kilometers (km2). Adina South & Adina West Lithium Project is situated in close proximity to the Adina Project, hosting the Adina and Jamar Prospects. The Margot Lake Project is in north-western Ontario, in the premium lithium region of Ontario’s Red Lakes Mining District. Lefroy Lithium Project is in the mineral-rich Goldfields region of Western Australia.
📈 Performance
Price History
-38.46%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in LU7
7
📊 Total Capital Earnings
$7K
🔃 Average investment frequency
15 weeks
💵 Average investment amount
$715
⏰ Last time a customer invested in LU7
31 days
LU7 investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
14%
50k - 100k
57%
Less than 50k
29%
👶 Age of investors
18 - 25
29%
26 - 34
35 - 90
71%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in LU7 also invest in...
IVV
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
20.59%
📊 Share price
$63.61 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
DHHF is an all-in-one investment solution, constructed using a passive blend of cost-effective ETFs traded on the ASX and other global exchanges. The ETF has a 100% allocation to shares, and is invested in a blend of large, mid and small cap equities from Australia, global developed and emerging markets, offering investors exposure to an ‘all-cap, all-world’ share portfolio with the potential for high growth over the long term. The ETF provides exposure to approximately 8,000 equity securities listed on over 60 global exchanges, in one ASX trade.
🙌 Performance (5Yr p.a)
9.13%
📊 Share price
$36.60 AUD
📈 HIGH PRICE GROWTH
🌏 GLOBAL
Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The firm is engaged in the development and commercialization of treatments for common skin diseases and infections. Its lead product is Sofpironium Bromide, for the treatment of primary axillary hyperhidrosis. The company also has a pipeline of other products in late-stage clinical studies for the treatment of moderate to severe rosacea, dermatitis, and acne respectively. The company also developing a topical antimicrobial product for the eradication of bacteria on the skin surface, initially in patients who are undergoing hemodialysis. Its BTX1503 product is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. Its BTX1702 product for the treatment of papulopustular rosacea. Its BTX 1204A canine study in Australia and New Zealand for atopic dermatitis. Its BTX1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus.
🙌 Performance (5Yr p.a)
63.91%
📊 Share price
$0.36 AUD
📦 LOGISTICS
NDQ
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
27.69%
📊 Share price
$50.98 AUD
🇺🇸 UNITED STATES
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
Want more shares? Try these...
Live Verdure Ltd. engages in the provision of hemp superfood and hemp skincare. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-12-14. The firm principal activities include the development and online sale of Australian beauty, functional food and nutraceutical products. The Company’s products are primarily sold direct-to-consumer (D2C). The firm is focused on delivering growth and business-wide optimizations by developing and deploying applications into the existing 13 Seeds and Edible Beauty business ecosystems using technology. The firm also leverages this technology to for new product development, in additional sectors and geographies to unlock growth. The Company’s subsidiaries include 13 Seeds Pty Ltd, 8Skincare Pty Ltd, Therajoint Pty Ltd, and The Beauty Apothecary Australia Pty Ltd.
📊 Share price
$0.79 AUD
🍔 FOOD PRODUCTS
LTR Pharma Ltd. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Brisbane, Queensland. The company went IPO on 2023-12-11. The firm is focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction (ED). Its lead product SPONTAN is set apart from existing ED therapies by its mechanism of action-intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less. SPONTAN (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction. The firm's subsidiary is LTR Pharma Inc.
📊 Share price
$0.84 AUD
📦 LOGISTICS
Liontown Resources Ltd. engages in the exploration and evaluation of minerals. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-12-27. The firm controls two major hard rock lithium deposits. The firm's projects include Kathleen Valley Project and Buldania Project. The Kathleen Valley Project is located in an established mining region about 60 kilometers north of Leinster and 680 kilometers north-east of Perth, Western Australia. The Kathleen Valley Lithium Project is a Tier-1 battery metals asset with excellent grade and scale in one of world's best mining districts. The Buldania Project is in the Eastern Goldfields Province of Western Australia, approximately 600 kilometers east of Perth. The Project is close to major road and rail infrastructure with direct access to the Port of Esperance 200 kilometers to the south. The firm's downstream expansion project includes investigating the potential for an integrated refinery to upgrade its spodumene from the Kathleen Valley mine to higher value lithium products.
🙌 Performance (5Yr p.a)
127.08%
📊 Share price
$0.54 AUD
⛏️ MINING